2025
SJR Q2
JCR Q3 · 1,8
99 matched articles
SCIE
Journal detail
Biological and Pharmaceutical Bulletin
- Publisher
- Pharmaceutical Society of Japan
- Country
- Japan · Asiatic Region
- Type
- journal
- ISSN
-
0918615813475215
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,518
- Quartile Q2
- H-Index 143
- Cites/doc 1,83
- Docs (3y) 781
- Cites (3y) 1.503
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,8
- 5Y JIF 1,9
- JCI 0,48
WoS indexes
- SCIE
Subject classification
Categories (SJR)
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,518 | 1,8 | 1,9 | 0,48 | Q3 | 143 |
| 2024 | Q2 | Q3 | 0,541 | 1,7 | 1,8 | 0,51 | Q3 | 139 |
| 2023 | Q2 | Q3 | 0,518 | 1,7 | 1,9 | 0,54 | Q3 | 139 |
| 2022 | Q2 | Q4 | 0,493 | 2 | 2,3 | 0,56 | Q3 | 139 |
| 2021 | Q2 | Q4 | 0,503 | 2,3 | 2,4 | 0,6 | Q3 | 139 |
| 2020 | Q2 | Q4 | 0,635 | 2,2 | 2,3 | 0,61 | Q3 | 139 |
| 2019 | Q2 | Q4 | 0,562 | 1,9 | 1,8 | 0,61 | Q3 | 139 |
| 2018 | — | Q4 | — | 1,5 | 1,8 | 0,63 | Q3 | — |
| 2017 | Q2 | Q4 | 0,626 | 1,7 | 1,8 | 0,63 | Q3 | 139 |
| 2016 | Q2 | Q3 | 0,667 | 1,7 | 1,9 | — | — | 139 |
| 2015 | Q1 | Q3 | 0,649 | 1,6 | 1,7 | — | — | 139 |
| 2014 | Q1 | Q3 | 0,774 | 1,8 | 1,9 | — | — | 139 |
| 2013 | Q1 | Q3 | 0,71 | 1,8 | 1,9 | — | — | 139 |
| 2012 | Q1 | Q3 | 0,731 | 1,8 | 2 | — | — | 139 |
| 2011 | Q1 | Q3 | 0,703 | 1,7 | 2 | — | — | 139 |
| 2010 | Q1 | Q3 | 0,744 | 1,8 | 2 | — | — | 139 |
| 2009 | — | Q3 | — | 1,8 | 1,9 | — | — | — |
| 2008 | — | Q3 | — | 1,8 | 1,9 | — | — | — |
| 2007 | — | Q3 | — | 1,6 | 1,7 | — | — | — |
| 2006 | — | Q3 | — | 1,5 | — | — | — | — |
| 2005 | — | Q3 | — | 1,3 | — | — | — | — |
| 2004 | — | Q3 | — | 1,4 | — | — | — | — |
| 2003 | — | Q3 | — | 1,1 | — | — | — | — |
| 2002 | — | Q3 | — | 1 | — | — | — | — |
| 2001 | — | Q3 | — | 0,8 | — | — | — | — |
| 2000 | — | Q3 | — | 0,9 | — | — | — | — |
| 1999 | — | Q3 | — | 0,8 | — | — | — | — |
| 1998 | — | Q3 | — | 0,8 | — | — | — | — |
| 1997 | — | Q3 | — | 0,9 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 258/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 256/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 251/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 218/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 219/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 211/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 205/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 215/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 198/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 187/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 187/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 161/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 161/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 163/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 170/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 153/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 148/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 137/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 133/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 125/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 130/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 116/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 130/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 125/188 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 137/186 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 128/181 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 116/175 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 109/178 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 102/157 |